New doping ban in tennis, the second one in the last 12 months at an elite level after Dan Evans's in June. Thomaz Bellucci announced on Thursday that he got a five-month ban, after being found positive in July 2017 during Bastad event, in Sweden, caught up with Hydrochlorothiazide, a diuretic often used as masking agent.
The Brazilian, who dropped to the 112th ranking position, claimed that there was a contamination in one of his supplements that he usually uses. 'I never took any kind of substance that advantaged me or that broke the fair play rules of the sport', Bellucci said. 'I would have never imagined that a supplement of a Pharmaceutical compounding could have a contamination with a minimum rate of dose.
It happened just when I was coming back from an injury, in an important transition during my career, I moved in Florida to train there and achieved my highest potential in the next few years', Bellucci added. The former world No.
21 got a 5-month ban that will end on January 31. He won't play Australian Open and will return to compete during the South American swing in Quito on clay. Considering that his action was unintentional, as proved by medical and scientific tests, ITF handed Bellucci a minimum ban.
During these months, Bellucci used had not played due to an Achilles tendon injury. Through a statement, ITF explained why the case wasn't made public. 'Under the Programme, only cases involving mandatory or voluntary provisional suspensions are announced prior to the issuance of a final decision.
'Bellucci promptly admitted his violation, but refused to accept a voluntary provisional suspension & therefore, remained free to compete pending resolution of his case', they added. Therefore, it cannot be considered as a silent ban.
Also Read: Getting to know Alex De Minaur